163 related articles for article (PubMed ID: 29190891)
1. High bone marrow
Zhou JD; Ma JC; Zhang TJ; Li XX; Zhang W; Wu DH; Wen XM; Xu ZJ; Lin J; Qian J
Oncotarget; 2017 Nov; 8(54):91979-91989. PubMed ID: 29190891
[TBL] [Abstract][Full Text] [Related]
2. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
3.
Zhang TJ; Zhou JD; Zhang W; Lin J; Ma JC; Wen XM; Yuan Q; Li XX; Xu ZJ; Qian J
Clin Epigenetics; 2018; 10():47. PubMed ID: 29643943
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia.
Zhou JD; Yang L; Zhu XW; Wen XM; Yang J; Guo H; Chen Q; Yao DM; Ma JC; Lin J; Qian J
Int J Clin Exp Pathol; 2015; 8(5):5336-44. PubMed ID: 26191235
[TBL] [Abstract][Full Text] [Related]
5. Distinct prognostic values of Annexin family members expression in acute myeloid leukemia.
Niu Y; Yang X; Chen Y; Jin X; Xie Y; Tang Y; Li L; Liu S; Guo Y; Li X; Duan L; Wang H
Clin Transl Oncol; 2019 Sep; 21(9):1186-1196. PubMed ID: 30694461
[TBL] [Abstract][Full Text] [Related]
6. Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.
Zhou JD; Yao DM; Han L; Xiao GF; Guo H; Zhang TJ; Li XX; Yuan Q; Yang L; Lin J; Qian J
Tumour Biol; 2017 Apr; 39(4):1010428317699123. PubMed ID: 28443469
[TBL] [Abstract][Full Text] [Related]
7. Increased
Li XX; Zhou JD; Wen XM; Zhang TJ; Wu DH; Deng ZQ; Zhang ZH; Lian XY; He PF; Yao XY; Lin J; Qian J
Onco Targets Ther; 2019; 12():3295-3304. PubMed ID: 31118680
[No Abstract] [Full Text] [Related]
8.
Zhou JD; Yao DM; Li XX; Zhang TJ; Zhang W; Ma JC; Guo H; Deng ZQ; Lin J; Qian J
Oncotarget; 2017 Sep; 8(39):66087-66097. PubMed ID: 29029494
[TBL] [Abstract][Full Text] [Related]
9. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
[TBL] [Abstract][Full Text] [Related]
10. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
11. High expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) is associated with poor prognosis in acute myeloid leukemia.
Zhou LY; Yin JY; Tang Q; Zhai LL; Zhang TJ; Wang YX; Yang DQ; Qian J; Lin J; Deng ZQ
Int J Clin Exp Pathol; 2015; 8(12):16073-80. PubMed ID: 26884884
[TBL] [Abstract][Full Text] [Related]
12. Id2 and E Proteins Orchestrate the Initiation and Maintenance of MLL-Rearranged Acute Myeloid Leukemia.
Ghisi M; Kats L; Masson F; Li J; Kratina T; Vidacs E; Gilan O; Doyle MA; Newbold A; Bolden JE; Fairfax KA; de Graaf CA; Firth M; Zuber J; Dickins RA; Corcoran LM; Dawson MA; Belz GT; Johnstone RW
Cancer Cell; 2016 Jul; 30(1):59-74. PubMed ID: 27374225
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia.
Wang CZ; Ma BB; Xu ZJ; Zhou JD; Zhang TJ; Chen Q; Yao DM; Lin J; Qian J; Sha S
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35506368
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of ID1 gene in acute myeloid leukemia].
Lu Y; Wang Q; Mu QT; Chen ZM; Lou JY; Ni WM; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):278-81. PubMed ID: 22781717
[TBL] [Abstract][Full Text] [Related]
15. [Proportion of CD34(+)CD38(-) cell population in bone marrow of patients with de novo AML as prognostic factor of complete remission at first course of induction chemotherapy].
Zhang CP; Wei H; Wang HJ; Huai L; He K; Chen YR; Lin D; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1268-72. PubMed ID: 22040986
[TBL] [Abstract][Full Text] [Related]
16. High Expression of CD300A Predicts Poor Survival in Acute Myeloid Leukemia.
Zhuang H; Li F; Si T; Pei R; Yu M; Chen D; Ye P; Lu Y
Acta Haematol; 2023; 146(3):196-205. PubMed ID: 36746134
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia.
Zhang J; Zhou J; Tang X; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Qian J; Deng ZQ
Oncotarget; 2017 Nov; 8(54):92536-92544. PubMed ID: 29190935
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation.
Zhao Q; Wang Y; Yu D; Leng JY; Zhao Y; Chu M; Xu Z; Ding H; Zhou J; Zhang T
BMC Cancer; 2022 Nov; 22(1):1229. PubMed ID: 36443709
[TBL] [Abstract][Full Text] [Related]
19. HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis.
Hao S; Shao Z
Int J Clin Exp Pathol; 2015; 8(6):7223-8. PubMed ID: 26261618
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia.
Bai J; Guo A; Hong Z; Kuai W
Onco Targets Ther; 2012; 5():213-9. PubMed ID: 23055746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]